Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation
Background A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unansw...
Gespeichert in:
Veröffentlicht in: | Digestive diseases and sciences 2021-02, Vol.66 (2), p.568-576 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 576 |
---|---|
container_issue | 2 |
container_start_page | 568 |
container_title | Digestive diseases and sciences |
container_volume | 66 |
creator | Xu, Mengque Cen, Mengsha Shen, Yuqin Zhu, Yubin Cheng, Fangli Tang, Linlin Hu, Weiling Dai, Ning |
description | Background
A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered.
Aims
The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation.
Methods
Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification.
Results
Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis.
Conclusions
These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis. |
doi_str_mv | 10.1007/s10620-020-06208-3 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2486621160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712933694</galeid><sourcerecordid>A712933694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</originalsourceid><addsrcrecordid>eNp9kVtr3DAQhUVpaTZp_0AegqDPTnRZj-TH7W4uC4H2oX0Wsi6Jgm1tJRuy_z5yNm0IhCIGHdB3htEchE4pOaeEiItMCTBSkbmKkBX_gBa0FrxiNciPaEEoFE0pHKHjnB8IIY2g8BkdcUYbWYNYoMeNi497cx-7YPDKBFttBzsZZ_H1NOLNPrch5pDxJuQ07caMv4fOPYP4chhdivdup8fiXYdkpq7IOGA9WPwzxT6OLuNtwfIYBt0V6Tvd98_QF_TJ6y67ry_3Cfp9dflrfVPd_rjerle3lamJHCvvLQfSgGgtA98yWjtvmGRMkNpagKbVWoMEKbnUVoLwQpJluzRAW22d5Sfo26HvLsU_U5lEPcQplWmyYksJMK-HvFJ3unMqDD6OSZs-ZKNWgrKGc2iWhTp_hyrHuj6YODhflvPWwA4Gk2LOyXm1S6HXaa8oUXOG6pChInPNGSpeTGcvE09t7-w_y9_QCsAPQC5Pw51Lr1_6T9snECunBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486621160</pqid></control><display><type>article</type><title>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Xu, Mengque ; Cen, Mengsha ; Shen, Yuqin ; Zhu, Yubin ; Cheng, Fangli ; Tang, Linlin ; Hu, Weiling ; Dai, Ning</creator><creatorcontrib>Xu, Mengque ; Cen, Mengsha ; Shen, Yuqin ; Zhu, Yubin ; Cheng, Fangli ; Tang, Linlin ; Hu, Weiling ; Dai, Ning</creatorcontrib><description>Background
A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered.
Aims
The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation.
Methods
Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification.
Results
Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis.
Conclusions
These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-020-06208-3</identifier><identifier>PMID: 32198567</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acids ; Analysis ; Animals ; Bile ; Bile Acids and Salts - metabolism ; Biochemistry ; Deoxycholic acid ; Deoxycholic Acid - administration & dosage ; Deoxycholic Acid - toxicity ; Development and progression ; Diet, Western - adverse effects ; Dysbiosis - chemically induced ; Dysbiosis - metabolism ; Dysbiosis - pathology ; Enterohepatic Circulation - drug effects ; Enterohepatic Circulation - physiology ; Feces ; Fibroblast growth factors ; Gastroenterology ; Gastrointestinal diseases ; Gastrointestinal Microbiome - drug effects ; Gastrointestinal Microbiome - physiology ; Gene expression ; Hepatology ; Inflammation ; Inflammatory bowel disease ; Inflammatory Bowel Diseases - chemically induced ; Inflammatory Bowel Diseases - metabolism ; Inflammatory Bowel Diseases - pathology ; Medicine ; Medicine & Public Health ; Mice ; Mice, Inbred C57BL ; Microbiota ; Microbiota (Symbiotic organisms) ; Oncology ; Original Article ; Risk factors ; RNA ; Transplant Surgery</subject><ispartof>Digestive diseases and sciences, 2021-02, Vol.66 (2), p.568-576</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>COPYRIGHT 2021 Springer</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</citedby><cites>FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</cites><orcidid>0000-0001-8476-6625</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10620-020-06208-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10620-020-06208-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32198567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Mengque</creatorcontrib><creatorcontrib>Cen, Mengsha</creatorcontrib><creatorcontrib>Shen, Yuqin</creatorcontrib><creatorcontrib>Zhu, Yubin</creatorcontrib><creatorcontrib>Cheng, Fangli</creatorcontrib><creatorcontrib>Tang, Linlin</creatorcontrib><creatorcontrib>Hu, Weiling</creatorcontrib><creatorcontrib>Dai, Ning</creatorcontrib><title>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><description>Background
A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered.
Aims
The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation.
Methods
Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification.
Results
Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis.
Conclusions
These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.</description><subject>Acids</subject><subject>Analysis</subject><subject>Animals</subject><subject>Bile</subject><subject>Bile Acids and Salts - metabolism</subject><subject>Biochemistry</subject><subject>Deoxycholic acid</subject><subject>Deoxycholic Acid - administration & dosage</subject><subject>Deoxycholic Acid - toxicity</subject><subject>Development and progression</subject><subject>Diet, Western - adverse effects</subject><subject>Dysbiosis - chemically induced</subject><subject>Dysbiosis - metabolism</subject><subject>Dysbiosis - pathology</subject><subject>Enterohepatic Circulation - drug effects</subject><subject>Enterohepatic Circulation - physiology</subject><subject>Feces</subject><subject>Fibroblast growth factors</subject><subject>Gastroenterology</subject><subject>Gastrointestinal diseases</subject><subject>Gastrointestinal Microbiome - drug effects</subject><subject>Gastrointestinal Microbiome - physiology</subject><subject>Gene expression</subject><subject>Hepatology</subject><subject>Inflammation</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory Bowel Diseases - chemically induced</subject><subject>Inflammatory Bowel Diseases - metabolism</subject><subject>Inflammatory Bowel Diseases - pathology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiota</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Risk factors</subject><subject>RNA</subject><subject>Transplant Surgery</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kVtr3DAQhUVpaTZp_0AegqDPTnRZj-TH7W4uC4H2oX0Wsi6Jgm1tJRuy_z5yNm0IhCIGHdB3htEchE4pOaeEiItMCTBSkbmKkBX_gBa0FrxiNciPaEEoFE0pHKHjnB8IIY2g8BkdcUYbWYNYoMeNi497cx-7YPDKBFttBzsZZ_H1NOLNPrch5pDxJuQ07caMv4fOPYP4chhdivdup8fiXYdkpq7IOGA9WPwzxT6OLuNtwfIYBt0V6Tvd98_QF_TJ6y67ry_3Cfp9dflrfVPd_rjerle3lamJHCvvLQfSgGgtA98yWjtvmGRMkNpagKbVWoMEKbnUVoLwQpJluzRAW22d5Sfo26HvLsU_U5lEPcQplWmyYksJMK-HvFJ3unMqDD6OSZs-ZKNWgrKGc2iWhTp_hyrHuj6YODhflvPWwA4Gk2LOyXm1S6HXaa8oUXOG6pChInPNGSpeTGcvE09t7-w_y9_QCsAPQC5Pw51Lr1_6T9snECunBA</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Xu, Mengque</creator><creator>Cen, Mengsha</creator><creator>Shen, Yuqin</creator><creator>Zhu, Yubin</creator><creator>Cheng, Fangli</creator><creator>Tang, Linlin</creator><creator>Hu, Weiling</creator><creator>Dai, Ning</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0001-8476-6625</orcidid></search><sort><creationdate>20210201</creationdate><title>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</title><author>Xu, Mengque ; Cen, Mengsha ; Shen, Yuqin ; Zhu, Yubin ; Cheng, Fangli ; Tang, Linlin ; Hu, Weiling ; Dai, Ning</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Analysis</topic><topic>Animals</topic><topic>Bile</topic><topic>Bile Acids and Salts - metabolism</topic><topic>Biochemistry</topic><topic>Deoxycholic acid</topic><topic>Deoxycholic Acid - administration & dosage</topic><topic>Deoxycholic Acid - toxicity</topic><topic>Development and progression</topic><topic>Diet, Western - adverse effects</topic><topic>Dysbiosis - chemically induced</topic><topic>Dysbiosis - metabolism</topic><topic>Dysbiosis - pathology</topic><topic>Enterohepatic Circulation - drug effects</topic><topic>Enterohepatic Circulation - physiology</topic><topic>Feces</topic><topic>Fibroblast growth factors</topic><topic>Gastroenterology</topic><topic>Gastrointestinal diseases</topic><topic>Gastrointestinal Microbiome - drug effects</topic><topic>Gastrointestinal Microbiome - physiology</topic><topic>Gene expression</topic><topic>Hepatology</topic><topic>Inflammation</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory Bowel Diseases - chemically induced</topic><topic>Inflammatory Bowel Diseases - metabolism</topic><topic>Inflammatory Bowel Diseases - pathology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiota</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Risk factors</topic><topic>RNA</topic><topic>Transplant Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Mengque</creatorcontrib><creatorcontrib>Cen, Mengsha</creatorcontrib><creatorcontrib>Shen, Yuqin</creatorcontrib><creatorcontrib>Zhu, Yubin</creatorcontrib><creatorcontrib>Cheng, Fangli</creatorcontrib><creatorcontrib>Tang, Linlin</creatorcontrib><creatorcontrib>Hu, Weiling</creatorcontrib><creatorcontrib>Dai, Ning</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Mengque</au><au>Cen, Mengsha</au><au>Shen, Yuqin</au><au>Zhu, Yubin</au><au>Cheng, Fangli</au><au>Tang, Linlin</au><au>Hu, Weiling</au><au>Dai, Ning</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>66</volume><issue>2</issue><spage>568</spage><epage>576</epage><pages>568-576</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><abstract>Background
A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered.
Aims
The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation.
Methods
Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification.
Results
Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis.
Conclusions
These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32198567</pmid><doi>10.1007/s10620-020-06208-3</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-8476-6625</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-2116 |
ispartof | Digestive diseases and sciences, 2021-02, Vol.66 (2), p.568-576 |
issn | 0163-2116 1573-2568 |
language | eng |
recordid | cdi_proquest_journals_2486621160 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Acids Analysis Animals Bile Bile Acids and Salts - metabolism Biochemistry Deoxycholic acid Deoxycholic Acid - administration & dosage Deoxycholic Acid - toxicity Development and progression Diet, Western - adverse effects Dysbiosis - chemically induced Dysbiosis - metabolism Dysbiosis - pathology Enterohepatic Circulation - drug effects Enterohepatic Circulation - physiology Feces Fibroblast growth factors Gastroenterology Gastrointestinal diseases Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - physiology Gene expression Hepatology Inflammation Inflammatory bowel disease Inflammatory Bowel Diseases - chemically induced Inflammatory Bowel Diseases - metabolism Inflammatory Bowel Diseases - pathology Medicine Medicine & Public Health Mice Mice, Inbred C57BL Microbiota Microbiota (Symbiotic organisms) Oncology Original Article Risk factors RNA Transplant Surgery |
title | Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A49%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deoxycholic%20Acid-Induced%20Gut%20Dysbiosis%20Disrupts%20Bile%20Acid%20Enterohepatic%20Circulation%20and%20Promotes%20Intestinal%20Inflammation&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Xu,%20Mengque&rft.date=2021-02-01&rft.volume=66&rft.issue=2&rft.spage=568&rft.epage=576&rft.pages=568-576&rft.issn=0163-2116&rft.eissn=1573-2568&rft_id=info:doi/10.1007/s10620-020-06208-3&rft_dat=%3Cgale_proqu%3EA712933694%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486621160&rft_id=info:pmid/32198567&rft_galeid=A712933694&rfr_iscdi=true |